LANA Ventures
VC Fund
LANA Ventures is a venture capital firm.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries LANA Ventures invests in
Stages LANA Ventures invests in
Countries LANA Ventures invests in
Round sizes
Round size
- Seed
- $2.8M–$7.4M
Investment Focus
Industry
- Health Care 2 (40%)
- Medical 1 (20%)
- Software 1 (20%)
- Life Science 1 (20%)
- Therapeutics 1 (20%)
Stage
- Seed 2 (40%)
- Pre-Seed 1 (20%)
Country
- Austria 2 (40%)
- Germany 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aitiologic is an Austrian precision medicine firm that creates AI-powered solutions for early disease identification and tailored therapy. | $7.4M / Seed / Sep 15, 2026 | ||
| UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries. | $3.1M / Pre-Seed / Apr 03, 2025 | ||
| XUND enables healthcare organizations to digitize patient interactions and turn data into actionable insights. Founded in 2018, the Vienna-based company provides better prevention, faster diagnosis and integrated monitoring with its Patient Interaction Suite.By leveraging cutting-edge Natural Language Processing (NLP) technology, we canautomatically analyze millions of medical publications to process data on 4,000+ condition concepts and thus reach unparalleled medical quality.The NLP technology results from more than 5 years of R&D and is a fundamental part of XUND's product development process as a medical device manufacturer. | $6.5M / Seed / Mar 05, 2025 | ||
| Aitiologic is an Austrian precision medicine firm that creates AI-powered solutions for early disease identification and tailored therapy. | $2.8M / Seed / Oct 01, 2024 | ||
| XUND enables healthcare organizations to digitize patient interactions and turn data into actionable insights. Founded in 2018, the Vienna-based company provides better prevention, faster diagnosis and integrated monitoring with its Patient Interaction Suite.By leveraging cutting-edge Natural Language Processing (NLP) technology, we canautomatically analyze millions of medical publications to process data on 4,000+ condition concepts and thus reach unparalleled medical quality.The NLP technology results from more than 5 years of R&D and is a fundamental part of XUND's product development process as a medical device manufacturer. | $5.8M / Seed / Sep 28, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does LANA Ventures invest in?
LANA Ventures invests primarily in Health Care, Medical and Software startups, most often at Seed and Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in Austria. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is LANA Ventures's check size?
LANA Ventures typically joins rounds of $2.8M–$7.4M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds LANA Ventures participates in.
When did LANA Ventures last invest?
The most recent investment recorded for LANA Ventures closed in Sep 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
